Illegal Making of Medical Devices, 45 Units under CDSCO scanner

Orthopedic implants were manufactured illegally without any regulatory license or approval. The Central Drugs Standard Control Organisation(CDSCO) team has raided 45 medical device facilities across the country for illegally producing orthopedic implants, cracking the whip on manufacturers making high-end life-saving devices without following quality standards and best practices.

The manufacturers are from Delhi, UP, Maharashtra, and Gujarat, as per officials statement. A senior official from CDSCO shared with the media that they issued show cause notices to them and the owner manufacturers have to explain the reason for the violation. Once we get their responses, action will be taken under provisions of the Drugs and Cosmetics Act.

These surprise raids were carried out by 125 officers divided into 37 inspection teams from the Central Drugs Standard Control Organisation. Drug inspectors found “dirty and filthy conditions” for manufacturing, lack of quality management and testing facilities as well as poor quality raw material.

Out of the four raided states, Delhi counted for the highest number of illegal facilities with the central regulatory teams conducting raids at 25 factories, whereas eight facilities were inspected in Maharashtra and six each in Gujarat and UP.

The use of medical devices is a rapidly growing segment in India, and these raids assume significance. Medical devices are particularly for high- end implants like cardiac and orthopedic implants where medical procedures are increasing swiftly despite the high prices of these devices and overall treatment. Presently, the Indian device manufacturing industry is pegged at $7 billion and is projected to reach $50 billion by 2025.

Related Posts

  • Pharma
  • July 24, 2025
  • 220 views
Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

  • Pharma
  • July 22, 2025
  • 298 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra